75.51% -0.555

Avenue Therapeutics Inc (ATXI)

Überblick Nachrichten Preisverlauf Financials Warum fällt ATXI? Forum Prognose Aktiensplit

Finanzdaten der Avenue Therapeutics Inc-Aktie (ATXI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31
Periodenlänge	3 Monate
Research and Development
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income/Loss From Continuing Operations After Tax
Net Income/Loss
Preferred Stock Dividends And Other Adjustments
Attributable To Noncontrolling Interest
Basic Average Shares
Basic Earnings Per Share
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic

INCY

$101.00

0.96%

MRNA

$52.03

0.13%

ROIV

$28.57

0.18%

BNTX

$110.40

1.44%

INSM

$150.75

0.65%

ONC

$318.31

1.15%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Offen in Reuters